Seminars in Cancer Biology, ISSN 1044-579X, 2015, Volume 34, pp. 58 - 69
Abstract Epstein-Bar virus (EBV) is known to directly drive the neoplastic transformation of lymphoid cells resulting in the development of a variety of...
Hematology, Oncology and Palliative Medicine | Epstein-Barr virus | Immune response | Microenvironment | Exosome | Lymphoma | NASOPHARYNGEAL CARCINOMA-CELLS | ONCOLOGY | BURKITTS-LYMPHOMA | MEMBRANE-PROTEIN 1 | PLASMODIUM-FALCIPARUM | REGULATORY T-CELLS | HODGKIN LYMPHOMA | LATENT MEMBRANE-PROTEIN-1 | NF-KAPPA-B | POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE | UP-REGULATION | Exosomes - metabolism | Epstein-Barr Virus Infections - virology | Signal Transduction | Immunomodulation | Herpesvirus 4, Human - physiology | Humans | Stromal Cells - metabolism | Cell Communication | Tumor Microenvironment | Bystander Effect | Neovascularization, Pathologic - etiology | Lymphoma - metabolism | Animals | B-Lymphocytes - immunology | Lymphoma - etiology | Stromal Cells - virology | B-Lymphocytes - virology | Biomarkers | Epstein-Barr Virus Infections - complications | Lymphoma - pathology | Neovascularization, Pathologic - metabolism | B-Lymphocytes - metabolism | Cell Transformation, Viral | Lymphomas | B cells
Hematology, Oncology and Palliative Medicine | Epstein-Barr virus | Immune response | Microenvironment | Exosome | Lymphoma | NASOPHARYNGEAL CARCINOMA-CELLS | ONCOLOGY | BURKITTS-LYMPHOMA | MEMBRANE-PROTEIN 1 | PLASMODIUM-FALCIPARUM | REGULATORY T-CELLS | HODGKIN LYMPHOMA | LATENT MEMBRANE-PROTEIN-1 | NF-KAPPA-B | POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE | UP-REGULATION | Exosomes - metabolism | Epstein-Barr Virus Infections - virology | Signal Transduction | Immunomodulation | Herpesvirus 4, Human - physiology | Humans | Stromal Cells - metabolism | Cell Communication | Tumor Microenvironment | Bystander Effect | Neovascularization, Pathologic - etiology | Lymphoma - metabolism | Animals | B-Lymphocytes - immunology | Lymphoma - etiology | Stromal Cells - virology | B-Lymphocytes - virology | Biomarkers | Epstein-Barr Virus Infections - complications | Lymphoma - pathology | Neovascularization, Pathologic - metabolism | B-Lymphocytes - metabolism | Cell Transformation, Viral | Lymphomas | B cells
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 04/2014, Volume 65, pp. 1 - 1
Human Immunodeficiency Virus (HIV)+ patients have an increased risk to develop lymphomas, including a significant fraction of histotypes associated with...
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 04/2014, Volume 65, Issue Suppl 2, pp. 67 - 67
Human Immunodeficiency Virus (HIV)+ patients have an increased risk to develop lymphomas, including a significant fraction of histotypes associated with...
Abstract
Abstract
Journal Article
Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 04/2014, Volume 65, p. 1
Human Immunodeficiency Virus (HIV)+ patients have an increased risk to develop lymphomas, including a significant fraction of histotypes associated with...
Antiretroviral drugs | Immunology | Human immunodeficiency virus--HIV | Lymphomas | T cell receptors | Viral infections | Virology
Antiretroviral drugs | Immunology | Human immunodeficiency virus--HIV | Lymphomas | T cell receptors | Viral infections | Virology
Journal Article
Haematologica, ISSN 0390-6078, 10/2010, Volume 95, Issue 10, pp. 1769 - 1777
The Epstein-Barr virus has evolved a plethora of strategies to evade immune system recognition and to establish latent infection in memory B cells, where the...
SOLID-ORGAN TRANSPLANTATION | METASTATIC MELANOMA | NASOPHARYNGEAL CARCINOMA | BONE-MARROW-TRANSPLANTATION | NUCLEAR ANTIGEN 1 | COMPLEX CLASS-I | POSITIVE HODGKINS-DISEASE | IN-VIVO EXPANSION | HEMATOLOGY | POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE | CYTOTOXIC T-LYMPHOCYTES | Hematologic Neoplasms - therapy | Immunotherapy, Adoptive | Hematologic Neoplasms - virology | Humans | Herpesvirus 4, Human - immunology | Epstein-Barr Virus Infections - complications | Immune Evasion - immunology | Review
SOLID-ORGAN TRANSPLANTATION | METASTATIC MELANOMA | NASOPHARYNGEAL CARCINOMA | BONE-MARROW-TRANSPLANTATION | NUCLEAR ANTIGEN 1 | COMPLEX CLASS-I | POSITIVE HODGKINS-DISEASE | IN-VIVO EXPANSION | HEMATOLOGY | POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE | CYTOTOXIC T-LYMPHOCYTES | Hematologic Neoplasms - therapy | Immunotherapy, Adoptive | Hematologic Neoplasms - virology | Humans | Herpesvirus 4, Human - immunology | Epstein-Barr Virus Infections - complications | Immune Evasion - immunology | Review
Journal Article
Autoimmunity Reviews, ISSN 1568-9972, 2007, Volume 7, Issue 2, pp. 96 - 101
Abstract Epstein–Barr virus (EBV) is a ubiquitous human γ-herpes virus that establishes a life-long asymptomatic infection in immunocompetent hosts by...
Allergy and Immunology | Post-transplantation lymphoproliferative disorders | B lymphocytes | Viral load | Epstein–Barr virus | Epstein-Barr virus | LYTIC INFECTION | DNA LOAD | PERIPHERAL-BLOOD | IMMUNOLOGY | viral load | ORGAN TRANSPLANT RECIPIENTS | POLYMERASE-CHAIN-REACTION | IN-VIVO | DISEASE | EBV | post-transplantation lymphoproliferative disorders | T-CELLS | Cytokines - metabolism | Epstein-Barr Virus Infections - virology | Epstein-Barr Virus Infections - immunology | Herpesvirus 4, Human - physiology | Humans | Lymphoproliferative Disorders - virology | Herpesvirus 4, Human - immunology | DNA, Viral - analysis | Lymphoproliferative Disorders - complications | Lymphoproliferative Disorders - immunology | Viral Load | Antigens, Viral - immunology | B-Lymphocytes - immunology | Organ Transplantation - adverse effects | Hematopoietic Stem Cell Transplantation - adverse effects | Lymphoma, B-Cell - immunology | B-Lymphocytes - virology | Epstein-Barr Virus Infections - complications | Lymphoma, B-Cell - virology | Virus Activation | Cytokines - immunology | Virus diseases | Proteins | Lymphocytes | Stem cells | Transplantation | Health aspects | Hematopoietic stem cells
Allergy and Immunology | Post-transplantation lymphoproliferative disorders | B lymphocytes | Viral load | Epstein–Barr virus | Epstein-Barr virus | LYTIC INFECTION | DNA LOAD | PERIPHERAL-BLOOD | IMMUNOLOGY | viral load | ORGAN TRANSPLANT RECIPIENTS | POLYMERASE-CHAIN-REACTION | IN-VIVO | DISEASE | EBV | post-transplantation lymphoproliferative disorders | T-CELLS | Cytokines - metabolism | Epstein-Barr Virus Infections - virology | Epstein-Barr Virus Infections - immunology | Herpesvirus 4, Human - physiology | Humans | Lymphoproliferative Disorders - virology | Herpesvirus 4, Human - immunology | DNA, Viral - analysis | Lymphoproliferative Disorders - complications | Lymphoproliferative Disorders - immunology | Viral Load | Antigens, Viral - immunology | B-Lymphocytes - immunology | Organ Transplantation - adverse effects | Hematopoietic Stem Cell Transplantation - adverse effects | Lymphoma, B-Cell - immunology | B-Lymphocytes - virology | Epstein-Barr Virus Infections - complications | Lymphoma, B-Cell - virology | Virus Activation | Cytokines - immunology | Virus diseases | Proteins | Lymphocytes | Stem cells | Transplantation | Health aspects | Hematopoietic stem cells
Journal Article
Cell death & disease, ISSN 2041-4889, 12/2016, Volume 7, Issue 12, pp. e2562 - e2562
Besides its canonical role in stabilizing telomeres, telomerase reverse transcriptase (TERT) may promote tumorigenesis through extra-telomeric functions. The...
DNA-DAMAGE RESPONSES | CANCER-CELLS | OXIDATIVE STRESS | ACTIVATION | LEUKEMIA-CELLS | DOWN-REGULATION | LYTIC CYCLE | DEATH | EPSTEIN-BARR-VIRUS | LYMPHOCYTES | CELL BIOLOGY | Aminobenzoates | Cell Survival - drug effects | Ataxia Telangiectasia Mutated Proteins - metabolism | Apoptosis - drug effects | Humans | Vidarabine - analogs & derivatives | Telomere - drug effects | Naphthalenes | B-Lymphocytes - drug effects | Vidarabine - pharmacology | Signal Transduction - drug effects | Cell Cycle Checkpoints - drug effects | Cyclophosphamide - pharmacology | B-Lymphocytes - virology | Telomerase - metabolism | S Phase - drug effects | Telomere - metabolism | Histones - metabolism | Telomerase - antagonists & inhibitors | Herpesvirus 4, Human - metabolism | Telomere Homeostasis - drug effects | B-Lymphocytes - metabolism | Cell Line, Transformed | Cellular biology | Telomerase | Cell cycle | Apoptosis | Original
DNA-DAMAGE RESPONSES | CANCER-CELLS | OXIDATIVE STRESS | ACTIVATION | LEUKEMIA-CELLS | DOWN-REGULATION | LYTIC CYCLE | DEATH | EPSTEIN-BARR-VIRUS | LYMPHOCYTES | CELL BIOLOGY | Aminobenzoates | Cell Survival - drug effects | Ataxia Telangiectasia Mutated Proteins - metabolism | Apoptosis - drug effects | Humans | Vidarabine - analogs & derivatives | Telomere - drug effects | Naphthalenes | B-Lymphocytes - drug effects | Vidarabine - pharmacology | Signal Transduction - drug effects | Cell Cycle Checkpoints - drug effects | Cyclophosphamide - pharmacology | B-Lymphocytes - virology | Telomerase - metabolism | S Phase - drug effects | Telomere - metabolism | Histones - metabolism | Telomerase - antagonists & inhibitors | Herpesvirus 4, Human - metabolism | Telomere Homeostasis - drug effects | B-Lymphocytes - metabolism | Cell Line, Transformed | Cellular biology | Telomerase | Cell cycle | Apoptosis | Original
Journal Article
Cancer Letters, ISSN 0304-3835, 2015, Volume 369, Issue 1, pp. 37 - 44
Highlights • PTLD represents the most severe complication of both hematopoietic stem cell and solid organ transplantations. • EBV is the main driver of PTLDs,...
Hematology, Oncology and Palliative Medicine | EBV | Latent/lytic viral cycle | PTLD | Treatment | Inflammation/immune activation | Telomerase | B-LYMPHOCYTES | VIRAL GENE-EXPRESSION | LIVER-TRANSPLANTATION | PERIPHERAL-BLOOD | SINGLE-CENTER-EXPERIENCE | POLYMERASE-CHAIN-REACTION | ONCOLOGY | KIDNEY-TRANSPLANTATION | IMMUNE ACTIVATION | STEM-CELL TRANSPLANTATION | EPSTEIN-BARR-VIRUS | Antiviral Agents - pharmacology | Epstein-Barr Virus Infections - virology | Antiviral Agents - therapeutic use | Virus Latency | Herpesvirus 4, Human - physiology | Humans | Lymphoproliferative Disorders - virology | Postoperative Complications - epidemiology | Epstein-Barr Virus Infections - drug therapy | Lymphoproliferative Disorders - pathology | Epstein-Barr Virus Infections - pathology | Lymphoproliferative Disorders - epidemiology | Postoperative Complications - virology | Animals | Organ Transplantation - adverse effects | Hematopoietic Stem Cell Transplantation - adverse effects | Lymphoproliferative Disorders - drug therapy | Postoperative Complications - drug therapy | Telomerase - antagonists & inhibitors | Epstein-Barr Virus Infections - epidemiology | Postoperative Complications - pathology | Epidemiology | Antiviral agents | Viral proteins | Cell death | Immunotherapy | Stem cells | Transplantation of organs, tissues, etc | Transplantation | B cells | Hematopoietic stem cells | Polymerase chain reaction | Competition | Pediatrics | Transplants & implants | Pathogenesis | Lymphomas | Adults
Hematology, Oncology and Palliative Medicine | EBV | Latent/lytic viral cycle | PTLD | Treatment | Inflammation/immune activation | Telomerase | B-LYMPHOCYTES | VIRAL GENE-EXPRESSION | LIVER-TRANSPLANTATION | PERIPHERAL-BLOOD | SINGLE-CENTER-EXPERIENCE | POLYMERASE-CHAIN-REACTION | ONCOLOGY | KIDNEY-TRANSPLANTATION | IMMUNE ACTIVATION | STEM-CELL TRANSPLANTATION | EPSTEIN-BARR-VIRUS | Antiviral Agents - pharmacology | Epstein-Barr Virus Infections - virology | Antiviral Agents - therapeutic use | Virus Latency | Herpesvirus 4, Human - physiology | Humans | Lymphoproliferative Disorders - virology | Postoperative Complications - epidemiology | Epstein-Barr Virus Infections - drug therapy | Lymphoproliferative Disorders - pathology | Epstein-Barr Virus Infections - pathology | Lymphoproliferative Disorders - epidemiology | Postoperative Complications - virology | Animals | Organ Transplantation - adverse effects | Hematopoietic Stem Cell Transplantation - adverse effects | Lymphoproliferative Disorders - drug therapy | Postoperative Complications - drug therapy | Telomerase - antagonists & inhibitors | Epstein-Barr Virus Infections - epidemiology | Postoperative Complications - pathology | Epidemiology | Antiviral agents | Viral proteins | Cell death | Immunotherapy | Stem cells | Transplantation of organs, tissues, etc | Transplantation | B cells | Hematopoietic stem cells | Polymerase chain reaction | Competition | Pediatrics | Transplants & implants | Pathogenesis | Lymphomas | Adults
Journal Article
Frontiers in Oncology, ISSN 2234-943X, 08/2018, Volume 8, p. 322
The efficacy of several therapeutic strategies against cancer, including cytotoxic drugs, radiotherapy, targeted immunotherapies and oncolytic viruses, depend...
Immune responses | Tumor microenvironment | Cancer immunotherapy | Interferons | Resistance mechanisms | HEPATOCELLULAR-CARCINOMA CELLS | ACQUIRED-RESISTANCE | TUMOR-CELLS | resistance mechanisms | immune responses | CHRONIC MYELOID-LEUKEMIA | NEGATIVE BREAST-CANCER | PHASE-III TRIAL | interferons | UNFOLDED PROTEIN RESPONSE | ONCOLOGY | cancer immunotherapy | GENE-EXPRESSION | tumor microenvironment | VESICULAR STOMATITIS-VIRUS | NF-KAPPA-B | Care and treatment | Innovations | Cellular signal transduction | Genetic aspects | Interferon | Drug resistance | Health aspects | Cancer
Immune responses | Tumor microenvironment | Cancer immunotherapy | Interferons | Resistance mechanisms | HEPATOCELLULAR-CARCINOMA CELLS | ACQUIRED-RESISTANCE | TUMOR-CELLS | resistance mechanisms | immune responses | CHRONIC MYELOID-LEUKEMIA | NEGATIVE BREAST-CANCER | PHASE-III TRIAL | interferons | UNFOLDED PROTEIN RESPONSE | ONCOLOGY | cancer immunotherapy | GENE-EXPRESSION | tumor microenvironment | VESICULAR STOMATITIS-VIRUS | NF-KAPPA-B | Care and treatment | Innovations | Cellular signal transduction | Genetic aspects | Interferon | Drug resistance | Health aspects | Cancer
Journal Article
10.
Full Text
Lymphomas occurring specifically in HIV-infected patients: From pathogenesis to pathology
Seminars in Cancer Biology, ISSN 1044-579X, 2013, Volume 23, Issue 6, pp. 457 - 467
Abstract Lymphomas that develop in HIV positive patients are predominantly aggressive B-cell malignancies. The most common HIV-associated lymphomas are Burkitt...
Hematology, Oncology and Palliative Medicine | EBV | Pathology | Pathogenesis | KSHV | HIV-associated lymphomas | HIV-lymphoma | SARCOMA-ASSOCIATED HERPESVIRUS | PRIMARY EFFUSION LYMPHOMA | B-CELL DIFFERENTIATION | ACTIVE-ANTIRETROVIRAL-THERAPY | KAPOSIS-SARCOMA | ONCOLOGY | PLASMABLASTIC LYMPHOMA | NON-HODGKIN-LYMPHOMA | SOLID LYMPHOMAS | GENE-EXPRESSION PROFILE | EPSTEIN-BARR-VIRUS | Burkitt Lymphoma - virology | Herpesvirus 8, Human - pathogenicity | Humans | Lymphoma, AIDS-Related - pathology | HIV Infections - complications | Herpesvirus 4, Human - pathogenicity | Sarcoma, Kaposi - virology | Castleman Disease - virology | Sarcoma, Kaposi - pathology | Lymphoma, AIDS-Related - virology | Sarcoma | Immunotherapy | Development and progression | HIV patients | Lymphomas | HIV (Viruses) | Health aspects | HIV infection
Hematology, Oncology and Palliative Medicine | EBV | Pathology | Pathogenesis | KSHV | HIV-associated lymphomas | HIV-lymphoma | SARCOMA-ASSOCIATED HERPESVIRUS | PRIMARY EFFUSION LYMPHOMA | B-CELL DIFFERENTIATION | ACTIVE-ANTIRETROVIRAL-THERAPY | KAPOSIS-SARCOMA | ONCOLOGY | PLASMABLASTIC LYMPHOMA | NON-HODGKIN-LYMPHOMA | SOLID LYMPHOMAS | GENE-EXPRESSION PROFILE | EPSTEIN-BARR-VIRUS | Burkitt Lymphoma - virology | Herpesvirus 8, Human - pathogenicity | Humans | Lymphoma, AIDS-Related - pathology | HIV Infections - complications | Herpesvirus 4, Human - pathogenicity | Sarcoma, Kaposi - virology | Castleman Disease - virology | Sarcoma, Kaposi - pathology | Lymphoma, AIDS-Related - virology | Sarcoma | Immunotherapy | Development and progression | HIV patients | Lymphomas | HIV (Viruses) | Health aspects | HIV infection
Journal Article
Blood, ISSN 0006-4971, 03/2016, Volume 127, Issue 11, pp. 1403 - 1409
Despite the immune reconstitution promoted by combined antiretroviral therapy (cART), lymphomas still represent the most common type of cancer in HIV-infected...
UNITED-STATES | B-CELL LYMPHOMA | IMMUNODEFICIENCY-VIRUS | PRIMARY EFFUSION LYMPHOMA | AIDS-RELATED LYMPHOMAS | EXPRESSION PROFILE | NON-HODGKIN-LYMPHOMA | INFECTED PATIENTS | ACTIVE-ANTIRETROVIRAL-THERAPY | HEMATOLOGY | TUMOR MICROENVIRONMENT | gag Gene Products, Human Immunodeficiency Virus - physiology | Humans | Lymphoma, AIDS-Related - etiology | Lymphoma, AIDS-Related - pathology | Gene Expression Regulation, Neoplastic | Tumor Microenvironment | Gene Expression Profiling | Genes, gag | B-Lymphocytes - virology | Lymphoma, B-Cell - virology | Clone Cells | B-Lymphocytes - pathology | Lymphoma, B-Cell - etiology | gag Gene Products, Human Immunodeficiency Virus - genetics | Lymphoma, AIDS-Related - virology | Lymphocyte Activation | HIV Antigens - physiology | Mice, Transgenic | HIV - pathogenicity | Lymphoma, AIDS-Related - classification | Animals | HIV Antigens - genetics | Germinal Center - virology | HIV - genetics | Mice | Immunocompromised Host | Cell Transformation, Viral | Review
UNITED-STATES | B-CELL LYMPHOMA | IMMUNODEFICIENCY-VIRUS | PRIMARY EFFUSION LYMPHOMA | AIDS-RELATED LYMPHOMAS | EXPRESSION PROFILE | NON-HODGKIN-LYMPHOMA | INFECTED PATIENTS | ACTIVE-ANTIRETROVIRAL-THERAPY | HEMATOLOGY | TUMOR MICROENVIRONMENT | gag Gene Products, Human Immunodeficiency Virus - physiology | Humans | Lymphoma, AIDS-Related - etiology | Lymphoma, AIDS-Related - pathology | Gene Expression Regulation, Neoplastic | Tumor Microenvironment | Gene Expression Profiling | Genes, gag | B-Lymphocytes - virology | Lymphoma, B-Cell - virology | Clone Cells | B-Lymphocytes - pathology | Lymphoma, B-Cell - etiology | gag Gene Products, Human Immunodeficiency Virus - genetics | Lymphoma, AIDS-Related - virology | Lymphocyte Activation | HIV Antigens - physiology | Mice, Transgenic | HIV - pathogenicity | Lymphoma, AIDS-Related - classification | Animals | HIV Antigens - genetics | Germinal Center - virology | HIV - genetics | Mice | Immunocompromised Host | Cell Transformation, Viral | Review
Journal Article
International Journal of Hematology, ISSN 0925-5710, 3/2011, Volume 93, Issue 3, pp. 281 - 293
Since 1995 to date, more than 250 patients with EBV-related diseases received virus-specific CTL. Cell therapy proved to be safe and effective, and achieved...
NPC | Medicine & Public Health | Hematology | EBV | Oncology | PTLD | CTL | CORD BLOOD | CYTOTOXIC T-LYMPHOCYTES | NASOPHARYNGEAL CARCINOMA | HODGKINS-DISEASE | ADOPTIVE TRANSFER | NUCLEAR ANTIGEN 1 | IN-VIVO EXPANSION | STEM-CELL TRANSPLANTATION | HEMATOLOGY | POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE | EPSTEIN-BARR-VIRUS | Hodgkin Disease - virology | T-Lymphocytes, Cytotoxic - immunology | Nasopharyngeal Carcinoma | Carcinoma | Epstein-Barr Virus Infections - immunology | Humans | Nasopharyngeal Neoplasms - therapy | Nasopharyngeal Neoplasms - virology | Clinical Trials as Topic | Adoptive Transfer | Herpesvirus 4, Human | T-Lymphocytes, Cytotoxic - transplantation | Epstein-Barr Virus Infections - therapy | Hodgkin Disease - therapy | Nasopharyngeal Neoplasms - immunology | Hodgkin Disease - immunology | Virus diseases | Antigens | Analysis | Immunotherapy | Stem cells | Transplantation of organs, tissues, etc | Lymphomas | Transplantation | T cells | Cancer | Nasopharyngeal carcinoma | Reviews | Immunoproliferative diseases | Prophylaxis | Chronic infection | Clinical trials | Cytotoxicity | Remission | Lymphocytes T | Malignancy | Hodgkin's disease
NPC | Medicine & Public Health | Hematology | EBV | Oncology | PTLD | CTL | CORD BLOOD | CYTOTOXIC T-LYMPHOCYTES | NASOPHARYNGEAL CARCINOMA | HODGKINS-DISEASE | ADOPTIVE TRANSFER | NUCLEAR ANTIGEN 1 | IN-VIVO EXPANSION | STEM-CELL TRANSPLANTATION | HEMATOLOGY | POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE | EPSTEIN-BARR-VIRUS | Hodgkin Disease - virology | T-Lymphocytes, Cytotoxic - immunology | Nasopharyngeal Carcinoma | Carcinoma | Epstein-Barr Virus Infections - immunology | Humans | Nasopharyngeal Neoplasms - therapy | Nasopharyngeal Neoplasms - virology | Clinical Trials as Topic | Adoptive Transfer | Herpesvirus 4, Human | T-Lymphocytes, Cytotoxic - transplantation | Epstein-Barr Virus Infections - therapy | Hodgkin Disease - therapy | Nasopharyngeal Neoplasms - immunology | Hodgkin Disease - immunology | Virus diseases | Antigens | Analysis | Immunotherapy | Stem cells | Transplantation of organs, tissues, etc | Lymphomas | Transplantation | T cells | Cancer | Nasopharyngeal carcinoma | Reviews | Immunoproliferative diseases | Prophylaxis | Chronic infection | Clinical trials | Cytotoxicity | Remission | Lymphocytes T | Malignancy | Hodgkin's disease
Journal Article
International Journal of Cancer, ISSN 0020-7136, 03/2017, Volume 140, Issue 6, pp. 1233 - 1245
The pathogenesis of classical Hodgkin lymphoma (cHL) is still enigmatic, largely because its tumor cells, the so‐called Hodgkin and Reed–Stenberg (HRS) cells,...
microenvironment | classical Hodgkin lymphoma | HIV‐associated Hodgkin lymphoma | pathogenesis | EBV‐associated Hodgkin lymphoma | Hodgkin lymphoma | EBV-associated Hodgkin lymphoma | HIV-associated Hodgkin lymphoma | REED-STERNBERG CELLS | CENTER B-CELLS | IMMUNODEFICIENCY-VIRUS | CLASSICAL HODGKIN | ONCOLOGY | MEMBRANE-PROTEIN 1 | REGULATORY T-CELLS | MONOCYTE-DERIVED MACROPHAGES | GENE-EXPRESSION | TUMOR-ASSOCIATED MACROPHAGES | EPSTEIN-BARR-VIRUS | Hodgkin Disease - virology | Antigens, CD - immunology | Antigens, CD - biosynthesis | Fibroblasts - physiology | Hodgkin Disease - pathology | Virus Latency | Humans | Lymphoma, AIDS-Related - etiology | Lymphoma, AIDS-Related - pathology | Neoplasm Proteins - physiology | Gene Expression Regulation, Neoplastic | Tumor Microenvironment | Viral Matrix Proteins - physiology | Cytokines - physiology | Hodgkin Disease - etiology | B-Lymphocyte Subsets - immunology | Immunocompetence | B-Lymphocyte Subsets - virology | Lymphoma, AIDS-Related - virology | Macrophages - physiology | Epstein-Barr Virus Infections - physiopathology | Epstein-Barr Virus Infections - virology | Signal Transduction | Lymphocyte Activation | Epstein-Barr Virus Infections - immunology | Hodgkin Disease - classification | Lymphoma, AIDS-Related - immunology | Discoidin Domain Receptor 1 - physiology | Comparative Genomic Hybridization | Models, Biological | Hodgkin Disease - immunology | Reed-Sternberg Cells - virology | Lymphocytes, Tumor-Infiltrating - immunology | Virus diseases | Analysis | Lymphomas | Epstein-Barr virus | HIV (Viruses) | Health aspects | HIV infection | Infections | Pathogenesis | Human immunodeficiency virus--HIV
microenvironment | classical Hodgkin lymphoma | HIV‐associated Hodgkin lymphoma | pathogenesis | EBV‐associated Hodgkin lymphoma | Hodgkin lymphoma | EBV-associated Hodgkin lymphoma | HIV-associated Hodgkin lymphoma | REED-STERNBERG CELLS | CENTER B-CELLS | IMMUNODEFICIENCY-VIRUS | CLASSICAL HODGKIN | ONCOLOGY | MEMBRANE-PROTEIN 1 | REGULATORY T-CELLS | MONOCYTE-DERIVED MACROPHAGES | GENE-EXPRESSION | TUMOR-ASSOCIATED MACROPHAGES | EPSTEIN-BARR-VIRUS | Hodgkin Disease - virology | Antigens, CD - immunology | Antigens, CD - biosynthesis | Fibroblasts - physiology | Hodgkin Disease - pathology | Virus Latency | Humans | Lymphoma, AIDS-Related - etiology | Lymphoma, AIDS-Related - pathology | Neoplasm Proteins - physiology | Gene Expression Regulation, Neoplastic | Tumor Microenvironment | Viral Matrix Proteins - physiology | Cytokines - physiology | Hodgkin Disease - etiology | B-Lymphocyte Subsets - immunology | Immunocompetence | B-Lymphocyte Subsets - virology | Lymphoma, AIDS-Related - virology | Macrophages - physiology | Epstein-Barr Virus Infections - physiopathology | Epstein-Barr Virus Infections - virology | Signal Transduction | Lymphocyte Activation | Epstein-Barr Virus Infections - immunology | Hodgkin Disease - classification | Lymphoma, AIDS-Related - immunology | Discoidin Domain Receptor 1 - physiology | Comparative Genomic Hybridization | Models, Biological | Hodgkin Disease - immunology | Reed-Sternberg Cells - virology | Lymphocytes, Tumor-Infiltrating - immunology | Virus diseases | Analysis | Lymphomas | Epstein-Barr virus | HIV (Viruses) | Health aspects | HIV infection | Infections | Pathogenesis | Human immunodeficiency virus--HIV
Journal Article